Adalimumab for the treatment of Crohn&rsquo;s disease

Código QR

Adalimumab for the treatment of Crohn&rsquo;s disease

Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi PorroDepartment of Clinical Sciences, Chair of Gastroenterology, &ldquo;Luigi Sacco&rdquo; University Hospital, Milan, ItalyIntroduction: Crohn&rsquo;s disease (CD) is a chronic inflammatory bowel disease characterized by...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/1eb50cbe23e1438183d461c303f6e725
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Natalizumab in the treatment of Crohn&rsquo;s disease
por: Danila Guagnozzi, et al.
Publicado: (2008)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Matteo Bosani, et al.
Publicado: (2009)

Maintenance treatment with infliximab for the management of Crohn&rsquo;s disease in adults
por: Renato Caviglia, et al.
Publicado: (2009)

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
por: Bosani M, et al.
Publicado: (2014)

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
por: Alvisi P, et al.
Publicado: (2019)

Rituximab in the treatment of non-Hodgkin&rsquo;s lymphoma
por: Beate Hauptrock, et al.
Publicado: (2008)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018)

Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
por: Jochen Schmitt, et al.
Publicado: (2009)

Capsule endoscopy in the diagnosis of Crohn’s disease
por: Niv Y
Publicado: (2013)

The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn&#39;s disease - An interview with David A Schwartz, 13 June 2007
por: David A Schwartz
Publicado: (2008)

Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by A&beta;1-42 in Alzheimer&rsquo;s disease models
por: Bernardi A, et al.
Publicado: (2012)

Association between Randall&rsquo;s plaque and calcifying nanoparticles
por: Neva &Ccedil;ift&ccedil;ioglu, et al.
Publicado: (2008)

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
por: Fonseca-Santos B, et al.
Publicado: (2015)

Magnetic nanoformulation of azidothymidine 5&rsquo;-triphosphate for targeted delivery across the blood&ndash;brain barrier
por: Zainulabedin M Saiyed, et al.
Publicado: (2010)

Efficacy of infliximab in refractory Beh&ccedil;et&rsquo;s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
por: Cantini F, et al.
Publicado: (2011)

Proposal for Alzheimer&rsquo;s diagnosis using molecular buffer and bus network
por: Mitatha S, et al.
Publicado: (2011)

Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn’s disease
por: Mario Gorenjak, et al.
Publicado: (2021)

Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi&rsquo;s sarcoma
por: Francesca Cainelli, et al.
Publicado: (2009)

Antitumor activity of silver nanoparticles in Dalton&rsquo;s lymphoma ascites tumor model
por: Muthu Irulappan Sriram, et al.
Publicado: (2010)

Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson&rsquo;s disease
por: Bossolasco P, et al.
Publicado: (2012)

Treatment of Parkinson&#39;s disease: nanostructured sol&ndash;gel silica&ndash;dopamine reservoirs for controlled drug release in the central nervous system
por: Tessy L&oacute;pez, et al.
Publicado: (2010)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze PG, et al.
Publicado: (2018)

Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021)

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
por: Cantini F, et al.
Publicado: (2012)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018)

Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
por: Petkau JM, et al.
Publicado: (2016)

Higher frequency of secretor phenotype in O blood group &ndash; its benefits in prevention and/or treatment of some diseases
por: Mohamad Salih Jaff
Publicado: (2010)

Características clínicas de presentación y evolutivas de una cohorte de 48 pacientes con enfermedad de Crohn en Uruguay
por: Beatriz Iade, et al.
Publicado: (2005)

Today’s diverse nano-theranostic applications and tomorrow’s promises
por: Webster TJ, et al.
Publicado: (2015)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
por: Linda Cingolani, et al.
Publicado: (2021)

Early stage and long term treatment of multiple sclerosis with interferon-&beta;
por: Angela Applebee, et al.
Publicado: (2009)

Long-term pegylated interferon-&alpha; and its potential in the treatment of melanoma
por: Reinhard Dummer, et al.
Publicado: (2009)

Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
por: Daham N, et al.
Publicado: (2020)

Nanocalcium-deficient hydroxyapatite&ndash;poly (&epsilon;-caprolactone)&ndash;polyethylene glycol&ndash;poly (&epsilon;-caprolactone) composite scaffolds
por: Wang Z, et al.
Publicado: (2012)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

New treatment options in the management of IBD &ndash; focus on colony stimulating factors
por: Josu&eacute; Barahona-Garrido, et al.
Publicado: (2008)